Interview with Prof. Silvia Giordani on Nanotechnology and Cancer Research Featured in L’Eco di Bergamo

In a recent interview, Prof. Silvia Giordani discussed her pioneering research in nanotechnology and its potential applications in cancer treatment. During her visit to the University of Bergamo, she explained how carbon nano-onions can be engineered to deliver anticancer drugs directly to tumour cells. By modifying the surface of these nanoparticles with specific molecular fragments, the team aims to guide them precisely to diseased cells, enabling targeted drug delivery while minimizing damage to healthy tissue, a key limitation of traditional chemotherapy. She also highlighted that her research has shown promising laboratory results in studies on pancreatic and breast cancer cells, with ongoing work exploring potential applications for brain tumours.

The interview also highlighted the recent recognition of Prof. Giordani as an Officer of the Order of Merit of the Italian Republic (OMRI), an honour acknowledging her significant contributions to nanoscience and biomedical research. Prof. Giordani noted that such recognition reflects the collaborative effort of her research teams, past and present and the growing impact of nanotechnology in medicine. Alongside discussing her achievements, she encouraged students to cultivate curiosity and critical thinking, emphasizing that asking questions and exploring interdisciplinary ideas are essential to advancing scientific discovery.